> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Since Our Last Issue ...
- URL: https://www.fdaweb.com/since-our-last-issue-49/
- Published: 2021-10-31T12:00:00.000Z
- Updated: 2026-09-14T17:20:54.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139703

China’s **Shandong Weigao Group Medical Polymer Co.** has agreed to acquire U.S.-based **Argon Medical Devices Holdings Inc.** for $850 million. Weigao is involved in the production and sale of medical devices, orthopedic and blood purification products, and it has been seeking opportunities to grow its product portfolio.

**Konica Minolta** and Boston-based **Invicro** have entered into an agreement whereby Konica Minolta will acquire Invicro, a provider of imaging services and software for research and drug development. Invicro is a global contract research organization provides a software and analytics platform enabling streamlined large-scale data analytics across any quantitative biomarker readout. Konica Minolta expects the transaction to accelerate development of its new medical platform to advance precision medicine, discover new therapeutic targets and develop new technologies and therapeutics.

**Avara Pharmaceutical Services** has signed an agreement with **GlaxoSmithKline** to acquire Glaxo’s consumer healthcare manufacturing facility in Aiken, SC. Avara is a contract manufacturing and technical services organization providing both active pharmaceutical ingredient formulation and manufacturing, along with secondary formulation, and manufacturing and packaging of small molecule drugs.